sFlt-1/PlGF ratio for prediction and diagnosis

Type: diagnostic

Status: FDA Approved (for certain indications)

Developer: Roche Diagnostics (Elecsys sFlt-1/PlGF ratio)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026